10.01.21
A world first, Australian-owned pain relief technology has been given all clear for use in Australia following the approval by the Therapeutic Goods Administration in July.
CareWear Australia, owned by Brisbane’s St Baker Energy Innovation Fund, has launched its adhesive printed light patches to relieve pain for the 3.9 million Australians affected by arthritis, as well as other pain sufferers and athletes.
The non-invasive technology is seen as a major step towards combatting Australia’s pre-scription opioid dependency when it comes to pain relief.
The product is the first to harness the power of advanced printed LED technology and PhotoBioModulation (PBM) Red Light Therapy to deliver safe, non-invasive treatment, without the harmful side effects and crippling addiction risk of opioids.
Currently used in trials at the Mater Hospital, early indications show the product has sig-nificantly reduced knee pain in trial participants, with a larger clinical trial planned for later this year to confirm the early results.
CareWear Australia CEO and physicist Dr. Eeshan Kulkarni said the patented technology’s use of pulsed light could put an end to the overuse of prescription pain relief medications.
“We’ve known that light can be used to improve our mental and physical health for dec-ades, whether that’s natural light from the sun or LED lights,” Dr. Kulkarni said. “By using different wavelengths of light, be it red and blue, we have created a printed therapy solution that our users can stick and forget.
“The CareWear patches are designed to deliver a controlled dose of light therapy and they’re adhesive so that can used by patients without assistance, which is really empower-ing for our users.
“We’ve started selling the product in America and received amazing feedback, with more than 100 professional sporting teams, including the gold medal winning American women’s basketball Olympics team, now using the product. We’re excited to bring the power of pulsed light to Australia,” he said.
CareWear is TGA and FDA approved and is already on sale in the United States, where it is manufactured.
In 2019, the technology was also awarded the Internet of Things/ Wearable Technologies (IoT/WT) Innovation World Cup for its product design, usability, innovation, and technol-ogy.
Dr. Kulkarni said he hoped CareWear would give Australians living with chronic pain ac-cess to a self-care solution.
CareWear will be available for sale later this year, both online (for now - www.carewear.net) and from a range of allied health clinics. The company is in talks with leading Australian health funds and hopes to have the unique technology added to the PBS to ensure that safe and affordable self-care is within reach of all Australians.
CareWear Australia, owned by Brisbane’s St Baker Energy Innovation Fund, has launched its adhesive printed light patches to relieve pain for the 3.9 million Australians affected by arthritis, as well as other pain sufferers and athletes.
The non-invasive technology is seen as a major step towards combatting Australia’s pre-scription opioid dependency when it comes to pain relief.
The product is the first to harness the power of advanced printed LED technology and PhotoBioModulation (PBM) Red Light Therapy to deliver safe, non-invasive treatment, without the harmful side effects and crippling addiction risk of opioids.
Currently used in trials at the Mater Hospital, early indications show the product has sig-nificantly reduced knee pain in trial participants, with a larger clinical trial planned for later this year to confirm the early results.
CareWear Australia CEO and physicist Dr. Eeshan Kulkarni said the patented technology’s use of pulsed light could put an end to the overuse of prescription pain relief medications.
“We’ve known that light can be used to improve our mental and physical health for dec-ades, whether that’s natural light from the sun or LED lights,” Dr. Kulkarni said. “By using different wavelengths of light, be it red and blue, we have created a printed therapy solution that our users can stick and forget.
“The CareWear patches are designed to deliver a controlled dose of light therapy and they’re adhesive so that can used by patients without assistance, which is really empower-ing for our users.
“We’ve started selling the product in America and received amazing feedback, with more than 100 professional sporting teams, including the gold medal winning American women’s basketball Olympics team, now using the product. We’re excited to bring the power of pulsed light to Australia,” he said.
CareWear is TGA and FDA approved and is already on sale in the United States, where it is manufactured.
In 2019, the technology was also awarded the Internet of Things/ Wearable Technologies (IoT/WT) Innovation World Cup for its product design, usability, innovation, and technol-ogy.
Dr. Kulkarni said he hoped CareWear would give Australians living with chronic pain ac-cess to a self-care solution.
CareWear will be available for sale later this year, both online (for now - www.carewear.net) and from a range of allied health clinics. The company is in talks with leading Australian health funds and hopes to have the unique technology added to the PBS to ensure that safe and affordable self-care is within reach of all Australians.